Neostigmine
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151512This classification denotes an acetylcholinesterase inhibitor with the molecular formula C12H19N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3982TWQ96G, chemically known as 3-trimethylammoniumphenyl n,n-dimethylcarbamate but generally known as neostigmine, which bears US NIH Compound Identifier 4456. European Medicines Agency schedules Neostigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03411MIG. World Health Organization schedules neostigmine in its Anatomical Therapeutic Chemical (ATC) Classification. NEOSTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, NEOSTIGMINE remains the US FDA Preferred Term for this commodity. Neostigmine bears US NLM identifiers UMLS ID C0027679 and NCI Concept Code C75024. SMILES: CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.